Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?

Verdict

Headline takes no side. We score ACXP +0.80 — strongly bullish.

Headline says

No call

No rating or direction in the headline

Expected · ACXP

+0.80strongly bullish

−1 bearish0bullish +1

More positive than 87% of ticker scores this week

Actual